Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Metabolism >> Lipid metabolism
Anti-Tafazzin / TAZ antibody
See all Tafazzin / TAZ products (4) ...
Goat polyclonal to Tafazzin / TAZ
This antibody is expected to recognise isoforms 1 to 4. (NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1, respectively).
WB, ELISAmore details
Reacts with
Human
Predicted to work with
Mouse, Rat, Dog, Chimpanzee
Synthetic peptide:C-HLKTQAEQLHNH (Human) from the C Terminus of the protein sequence (according to NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1.).
C-HLKTQAEQ LHNH
Human heart lysate.
Liquid
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.02% Sodium Azide
Constituents: 0.5% BSA, Tris buffered saline, pH 7.3
Concentration information loading...
Immunogen affinity purified
Polyclonal
IgG
Western blot - Tafazzin / TAZ antibody (ab40004)
(enlarge)
Our Abpromise guarantee covers the use of ab40004 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ELISA: 1/32000 - antibody limit dilution.
WB: Use at a concentration of 0.3 - 1 µg/ml. Detects a band of approximately 28 kDa (predicted molecular weight: 33 kDa).
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Some isoforms may be involved in cardiolipin (CL) metabolism.
High levels in cardiac and skeletal muscle. Up to 10 isoforms can be present in different amounts in different tissues. Most isoforms are ubiquitous. Isoforms that lack the N-terminus are found in leukocytes and fibroblasts, but not in heart and skeletal muscle. Some forms appear restricted to cardiac and skeletal muscle or to leukocytes.
Defects in TAZ are the cause of 3-methylglutaconic aciduria type 2 (MGA2) [MIM:302060]; also known as Barth syndrome. MGA2 is a severe metabolic disorder, often fatal in childhood, characterized by dilated cardiomyopathy, skeletal myopathy, short stature, neutropenia and 3-methylglutaconicaciduria.
Defects in TAZ are the cause of left ventricular non-compaction X-linked (LVNCX) [MIM:300183]. LVNC is due to an arrest of myocardial morphogenesis. The disorder is characterized by a hypertrophic left ventricular with deep trabeculations and with poor systolic function, with or without associated left ventricular dilation. In some cases, the right ventricle is also affected.
Belongs to the taffazin family.
The hydrophilic domain may serve as an exposed loop interacting with other proteins.
Cytoplasm and Membrane.
Target information above from: UniProt accessionQ16635
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - Tafazzin / TAZ antibody (ab40004)

Anti-Tafazzin / TAZ antibody (ab40004) at 0.3 µg/ml + Human Heart lysate in RIPA buffer at 35 µg
Predicted band size : 33 kDa
Observed band size : 28 kDa (why is the actual band size different from the predicted?)
Primary incubation was 1 hour. Detected by chemiluminescence.
This product has been referenced in:
See 1 publication for this product
Publishing research using ab40004? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

Anti-Tafazzin / TAZ antibody (ab40004) at 0.3 µg/ml + Human Heart lysate in RIPA buffer at 35 µg
Predicted band size : 33 kDa
Observed band size : 28 kDa (why is the actual band size different from the predicted?)
Primary incubation was 1 hour. Detected by chemiluminescence.
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
